Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MP Biomedicals™ Bovine Fibrinogen 90% Clottable

Catalog No. MP8820226 Shop All MP Biomedicals, Inc Products
Change view
Click to view available options
Quantity:
50 g
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
MP8820226 50 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. MP8820226 Supplier MP Biomedicals™ Supplier No. 08820226
Only null left
Add to Cart
Add to Cart

A blood protein that is involved in clotting and is converted to fibrin by thrombin

Fibrinogen has an approximate molecular weight of 340kDa. It consists of three non-identical pairs of disulfidebonded chains. The α-chain has an approximate molecular weight of 63.5kDa, the β-chain 56kDa, and the γ-chain 47kDa. At the amino termini, the three chains are connected in a dimeric disulfide knot (DSK). A second DSK occurs later in the molecule. Fibrinogen has approximately 4% carbohydrate content.

Bovine fibrinogen has been used in studies of haemostatic therapy in surgical and massive trauma patients. These studies have shown that fibrinogen may prove to be more superior in stopping blood loss when compared to using fresh frozen plasma (FFP). It can be used for preparation of fibrin plates for analysis of fibrinolytic enzymes, a substrate for clotting assays, and study of fibrinogen degradation products.

Fibrinogen is an acute phase protein that is part of the coagulation cascade of proteins. The end result of the cascade is the production of thrombin that converts fibrinogen to fibrin. Thrombin rapidly proteolyzes fibrinogen, releasing fibrinopeptide A. The loss of this small peptide is not sufficient to make the resulting fibrin molecule insoluble, but it tends to form complexes with adjacent fibrin and fibrinogen molecules. Thrombin then cleaves a second peptide, fibrinopeptide B, from fibrin and the fibrin monomers formed then polymerize spontaneously to form an insoluble gel. The polymerized fibrin is held together by noncovalent and electrostatic forces and stabilized by the transamidating enzyme, factor XIIIa, that is produced by the action of thrombin on factor XIII. The insoluble fibrin aggregates (clots) and aggregated platelets then block the damaged blood vessel and prevent further bleeding. The amount of fibrinogen in the plasma can serve as a nonspecific indicator of whether or not an inflammatory process is present in the body. Fibrinogen from any mammalian source will be cleaved by thrombin from any mammalian source.

  • Diagnostic Grade
  • White Powder
  • Synonyms: Factor I, Fibrinogen from New Zealand sourced bovine plasma
  • CAS Number: 9001-32-5
  • Molecular Weight: α-chain mol wt 63.5kDa, β-chain mol wt 56kDa, γ-chain mol wt 47kDa (about 4% carbohydrate content), soluble dimer mol wt 340kDa (Lit.)
  • EC Number: 232-598-6
  • MDL Number: MFCD00163624

TRUSTED_SUSTAINABILITY

Specifications

Name Bovine Fibrinogen 90% Clottable from Bovine Plasma
Quantity 50 g
Form Lyophilized
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.